The Ola Digital Health alternative that operates the program, not just the platform.

Ola Digital Health published no pricing of any kind as of September 8, 2026: no pricing page, no tiers, and no dollar figures across its homepage, blog, press releases, release notes, or terms. Its contact form routes you by product interest (telehealth platform, physician services, pharmacy services, or partnership), so every number arrives from sales. Two things it does publish are worth more than a headline price when you scope it. The clinical layer is a named third party rather than its own medical group, which tells you consult economics are a separate negotiation from the software. And it ships public release notes, twelve of them dated through June 2026, so you can read what actually changed in the product before you sign — which is rare enough in this category to be worth saying plainly.

EmbedCare prices the operated stack as flat product rates fixed in your partner agreement, with medication included on GLP-1 programs and a self-serve Launch tier starting at $495/mo. The comparison is not really price against price, since one side has no published price at all: it is whether you are buying a platform plus a brokered clinical network and running the program yourself, or buying the program run for you.

Third-party review coverage of Ola Digital Health is thin: B2B telehealth infrastructure is bought through demos and references, not review marketplaces, so G2, Capterra, and Trustpilot listings in this category are sparse or unclaimed. Search those platforms for the current state, then weigh reference calls more heavily than star counts.

One relationship to know before you shortlist: Ola displays a WellSync logo in its own client strip and names WellSync twice in its own public release notes as a live integration, once in a prescription-visibility bug fix and once in an access-token change. That is Ola’s claim, on Ola’s site. WellSync’s own homepage did not mention Ola at a September 8, 2026 check, and we have not established the direction or the substance of the arrangement. Integration evidence shows the products talk to each other; it does not show who supplies whom, so put the question to both. An integration between independently sold products leaves you two real choices; one vendor supplying the other leaves you one. We publish a WellSync comparison too, and it carries this same note.

There is no Trustpilot profile for its domain (a 404 at a September 8, 2026 check) and no G2 or Capterra listing surfaced. Two research traps are worth knowing before you search. Name collisions: results for “Ola” reviews return the ride-hailing company, oladoc.com, and oladoctor.com, all unrelated to this vendor and none of whose scores transfer. And its homepage carries an unlinked “Featured in” logo strip (Bloomberg, Business Insider, MarketWatch and others) alongside a press page holding only two releases, both from October 2024 — the shape of newswire syndication rather than earned coverage, so read those logos as distribution, not as reporting.

Whichever vendor you pick, ask for two reference calls with operators at your volume, and ask both the same three questions: what does a fill actually cost you all-in, who owns the patient record if you leave, and what happened the last time something broke on a Friday.